NMRA
Neumora Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Neumora Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
112 managers report $139.6M of Neumora Therapeutics on form 13F for the quarter ended Jun 30 '26. 21 of them hold 80% of it; Siren is largest at 10.35%.
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | SirenSiren | $14.4M | 10.35% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $13.2M | 9.49% | +279.29% | |
| 3 | Softbank GroupSoftbank | $10.4M | 7.42% | 0.00% | |
| 4 | Tudor Investment Corp ET ALTudor Investment Corp ET AL | $8.8M | 6.32% | +291.32% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $7.9M | 5.69% | +19.98% | |
| 6 | MIC Capital Management UKMIC Capital Management UK | $7.6M | 5.43% | 0.00% | |
| 7 | FMRFMR | $5.9M | 4.26% | +0.01% | |
| 8 | WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUSTWELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $5.6M | 4.03% | 0.00% | |
| 9 | Geode Capital ManagementGeodeindex-like | $4.4M | 3.18% | +139.89% | |
| 10 | ICONIQ CapitalICONIQ Capital | $4.4M | 3.12% | 0.00% | |
| 11 | Two Sigma InvestmentsTwo Sigma | $3.8M | 2.73% | +10.22% | |
| 12 | Orbimed AdvisorsOrbimed | $3.6M | 2.61% | new | |
| 13 | Lunate CapitalLunate Capital | $3.6M | 2.59% | 0.00% | |
| 14 | Boxer Capital ManagementBoxer | $3.4M | 2.44% | new | |
| 15 | Johnson & JohnsonJohnson & Johnson | $3.1M | 2.25% | 0.00% | |
| 16 | State StreetState Streetindex-like | $2.7M | 1.93% | +296.80% | |
| 17 | Caption ManagementCaption | $2.3M | 1.68% | +32.11% | |
| 18 | Ikarian CapitalIkarian Capital | $2.2M | 1.56% | 0.00% | |
| 19 | Renaissance TechnologiesRenaissance Technologies | $2.1M | 1.54% | −9.12% | |
| 20 | Affinity Asset AdvisorsAffinity Asset | $1.8M | 1.30% | new | |
| 21 | Citadel AdvisorsCitadel | $1.8M | 1.30% | +153.92% | |
| 22 | Marshall WaceMarshall Wace | $1.5M | 1.10% | −24.33% | |
| 23 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.5M | 1.09% | +384.10% | |
| 24 | Charles Schwab Investment ManagementCharles Schwabindex-like | $1.4M | 1.00% | +59.55% | |
| 25 | Northern TrustNorthern Trustindex-like | $1.4M | 0.98% | +306.63% |
Fund move
No thesis.
Neumora Therapeutics, Inc.
0.36
No implied move.
No implied move.
Expected move
No implied move.